| Author (Year) |
Trial |
? vs ? |
# of Pts |
Clinical Indication |
Results |
| Saxon (2003) [45] |
Single centre reporting experience from multicentre trial |
PTFE stent vs PTA (Viabahn) |
28 |
Claudicants |
Clinical improvement no different. Conclusion different from reported results. Trial closed 1999. |
| Saxon (2008) [101] |
RCT as from Saxon (2003) |
PTFE stent plus PTA vs PTA (Viabahn) |
100 |
Claudicants |
Same trial as above restarted. Flawed methodology. |
| Lammer (2013) [67] |
RCT long lesions |
Viabahn heprin bonded vs BMS |
141 |
Claudicants |
No difference in 12-month primary patency or incidence of TLR. |
| Reijnen (2017) [102] |
RCT multicentre |
Heparin bonded endoluminal stent vs FP bypass |
129 |
CLI 38% endoluminal and 32% surgical. Both groups 2/3 Rutherford class 2/3 |
No difference in outcomes between 2 groups. Results similar to BASil trial, but including claudicants. |